- Home
- TNGX vs ONBPO Comparison
TNGX vs ONBPO Comparison
Compare TNGX & ONBPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ONBPO
- Stock Information
- Founded
- TNGX 2014
- ONBPO N/A
- Country
- TNGX United States
- ONBPO United States
- Employees
- TNGX N/A
- ONBPO 4028
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ONBPO Major Banks
- Sector
- TNGX Health Care
- ONBPO Finance
- Exchange
- TNGX Nasdaq
- ONBPO Nasdaq
- Market Cap
- TNGX 351.2M
- ONBPO N/A
- IPO Year
- TNGX N/A
- ONBPO N/A
- Fundamental
- Price
- TNGX $5.63
- ONBPO $24.88
- Analyst Decision
- TNGX Strong Buy
- ONBPO
- Analyst Count
- TNGX 6
- ONBPO 0
- Target Price
- TNGX $12.20
- ONBPO N/A
- AVG Volume (30 Days)
- TNGX 3.3M
- ONBPO N/A
- Earning Date
- TNGX 08-06-2025
- ONBPO N/A
- Dividend Yield
- TNGX N/A
- ONBPO N/A
- EPS Growth
- TNGX N/A
- ONBPO N/A
- EPS
- TNGX N/A
- ONBPO N/A
- Revenue
- TNGX $40,990,000.00
- ONBPO N/A
- Revenue This Year
- TNGX N/A
- ONBPO N/A
- Revenue Next Year
- TNGX N/A
- ONBPO N/A
- P/E Ratio
- TNGX N/A
- ONBPO N/A
- Revenue Growth
- TNGX 10.09
- ONBPO N/A
- 52 Week Low
- TNGX $1.03
- ONBPO N/A
- 52 Week High
- TNGX $12.02
- ONBPO N/A
- Technical
- Relative Strength Index (RSI)
- TNGX 78.55
- ONBPO 52.49
- Support Level
- TNGX $4.80
- ONBPO $24.78
- Resistance Level
- TNGX $5.96
- ONBPO $25.09
- Average True Range (ATR)
- TNGX 0.51
- ONBPO 0.15
- MACD
- TNGX -0.02
- ONBPO 0.01
- Stochastic Oscillator
- TNGX 92.95
- ONBPO 46.39
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About ONBPO Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.